|
Advanced Search |
|
|
Home |
| Browse | |
|
|
Communities & Collections |
|
|
Publication Year |
|
Author |
|
|
Title |
|
|
JRC Publication N° |
|
|
Publication Type |
|
|
eBooks |
Browsing by Author EPSTEIN A
|
|
Showing results 1 to 2 of 2
| Publication Year | Title | Author(s), Editor(s), Other Contributor(s) | Publication Type |
|---|---|---|---|
| 2012 | Radioimmunotherapy of pancreatic cancer with 213Bi-labeled antibodies to intranuclear histones | DADACHOVA E.; BRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; SELLERS R.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; EPSTEIN A | Contributions to Conferences |
| 2013 | Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA in combination with cisplatin and gemcitabine | BRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; ONYEDIKA C; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SELLERS R.; EPSTEIN A, et al | Contributions to Conferences |
Showing results 1 to 2 of 2
| The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national. |
